<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jalily PH</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>Heart and Stroke Foundation</funding><funding>Heart and Stroke Foundation of Canada</funding><funding>Natural Sciences and Engineering Research Council</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>10647</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9503309</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(18)</volume><pubmed_abstract>The coronavirus E proteins are small membrane proteins found in the virus envelope of alpha and beta coronaviruses that have a high degree of overlap in their biochemical and functional properties despite minor sequence variations. The SARS-CoV-2 E is a 75-amino acid transmembrane protein capable of acting as an ion channel when assembled in a pentameric fashion. Various studies have found that hexamethylene amiloride (HMA) can inhibit the ion channel activity of the E protein in bilayers and also inhibit viral replication in cultured cells. Here, we use the available structural data in conjunction with homology modelling to build a comprehensive model of the E protein to assess potential binding sites and molecular interactions of HMA derivatives. Furthermore, we employed an iterative cyc</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein.</pubmed_title><pmcid>PMC9503309</pmcid><funding_grant_id>PJT-156181</funding_grant_id><funding_grant_id>RGPIN-2016-05422</funding_grant_id><funding_grant_id>G-17-0018392</funding_grant_id><funding_grant_id>PJT-175024</funding_grant_id><funding_grant_id>G-21-0031566</funding_grant_id><funding_grant_id>00-00</funding_grant_id><pubmed_authors>Jalily PH</pubmed_authors><pubmed_authors>Fedida D</pubmed_authors><pubmed_authors>Jalily Hasani H</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein.</name><description>The coronavirus E proteins are small membrane proteins found in the virus envelope of alpha and beta coronaviruses that have a high degree of overlap in their biochemical and functional properties despite minor sequence variations. The SARS-CoV-2 E is a 75-amino acid transmembrane protein capable of acting as an ion channel when assembled in a pentameric fashion. Various studies have found that hexamethylene amiloride (HMA) can inhibit the ion channel activity of the E protein in bilayers and also inhibit viral replication in cultured cells. Here, we use the available structural data in conjunction with homology modelling to build a comprehensive model of the E protein to assess potential binding sites and molecular interactions of HMA derivatives. Furthermore, we employed an iterative cyc</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-04-08T11:50:05.526Z</modification><creation>2025-02-19T00:44:03.92Z</creation></dates><accession>S-EPMC9503309</accession><cross_references><pubmed>36142556</pubmed><doi>10.3390/ijms231810647</doi></cross_references></HashMap>